Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Review · December 13, 2022

Health-Related Quality of Life in Patients With Breast Cancer Treated With CDK4/6 Inhibitors

ESMO Open

 

Additional Info

ESMO Open
Health-related quality of life in breast cancer patients treated with CDK4/6 inhibitors: a systematic review
ESMO Open 2022 Dec 01;7(6)100629, V Di Lauro, G Barchiesi, F Martorana, G Zucchini, M Muratore, C Fontanella, G Arpino, L Del Mastro, M Giuliano, F Puglisi, M De Laurentiis

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading